Famvir (famciclovir) is licensed for herpes zoster, recurrent genital herpes and recurrent herpes labialis, and FDA-approved generic famciclovir tablets from multiple manufacturers now sit alongside the originator brand on most formularies.
M Care Exports supplies Famvir (famciclovir), the oral prodrug of penciclovir, as an antiviral for herpes zoster and recurrent herpes simplex. We source the originator brand and FDA and MHRA-approved generic famciclovir tablets through licensed Indian distribution and manufacturing channels, dispatching on quote rather than from our own manufacturing.
Famciclovir exporter and bulk supplier from India.
For hospital, wholesaler and tender-desk orders, M Care quotes famciclovir tablets against buyer specification: brand (Famvir) or generic, strength mix (125 mg, 250 mg, 500 mg) and destination-market regulatory documentation, drawn from licensed WHO-GMP manufacturer lines on the M Care roster. Because famciclovir's dosing regimen changes by indication rather than by a single fixed dose, we confirm the buyer's intended indication mix, herpes zoster, recurrent genital herpes or suppressive therapy, before dispatch, then align CTD/eCTD or country-specific dossier paperwork to the destination regulator's requirements.
Source
WHO-GMP-certified Indian manufacturing line, named on every quote.
Minimum order
No blanket MOQ. Set by the source manufacturer's minimum batch-release quantity for the strength and pack ordered.
Pricing
On request. Indicative FOB or CIF quote, formal proforma on confirmation.
Incoterms
EXW, FOB, CIF, CIP or DAP.
Payment
Letter of credit (sight or usance) and telegraphic transfer.
Documentation
WHO-GMP certificate of the source line, product-specific CoPP, batch CoA, method of analysis, Free Sale Certificate, Certificate of Origin, CTD or eCTD dossier. On request.
Shelf-life
Minimum remaining shelf-life agreed per order and confirmed on the proforma.
Response
Availability and CoPP status within two working days; pre-alert documents before dispatch.
Antiviral; deoxynucleoside analogue DNA polymerase inhibitor (penciclovir prodrug), sourced and documented for export.
Famciclovir is a deoxynucleoside analogue DNA polymerase inhibitor: once absorbed, it converts rapidly to penciclovir, which is phosphorylated inside virus-infected cells and blocks herpesvirus DNA replication. It is dosed orally, not injected, and needs no reconstitution. The FDA label's flagship indications are herpes zoster (shingles) in immunocompetent adults, recurrent episodes and suppressive therapy of genital herpes, recurrent herpes labialis (cold sores), and recurrent orolabial or genital herpes in HIV-infected adults; it is not indicated for first-episode genital herpes or ophthalmic zoster. It is supplied as 125 mg, 250 mg and 500 mg film-coated tablets. Dosing is regimen-specific: 500 mg every 8 hours for 7 days for herpes zoster, 1000 mg twice daily for 1 day for recurrent genital herpes, 1500 mg as a single dose for herpes labialis, and 250 mg twice daily for suppressive therapy, with dose reduction required in renal impairment.
Active ingredient
Famciclovir. Antiviral; deoxynucleoside analogue DNA polymerase inhibitor (penciclovir prodrug).
Forms and strengths
125 mg film-coated tablet; 250 mg film-coated tablet; 500 mg film-coated tablet.
Indications
Famciclovir, the oral prodrug of penciclovir, is an antiviral indicated for herpes zoster, recurrent genital herpes, recurrent herpes labialis and, in HIV-infected adults, recurrent orolabial or genital herpes. Supplied as originator Famvir and licensed generic tablets from Indian WHO-GMP facilities to regulated and semi-regulated markets outside India.
Administration
Oral. Film-coated tablet.
Documentation
Batch-specific CoA, CoPP, manufacturing-site WHO-GMP certificate and stability data compiled per consignment, in the format the destination regulator expects.
Hospital pharmacies, licensed importers and tender desks across our export markets.
India is our origin. We do not sell into the Indian market.
Buyers for famciclovir are mainly hospital and outpatient pharmacies managing shingles and recurrent genital herpes, national and regional MoH tender desks running antiviral and dermatology formulary lists, licensed pharmaceutical wholesalers and importers, and HIV-care programmes and NGO procurement supporting herpes-management access where local registration is in place. India is our origin, not a market we sell into; famciclovir is exported only.
GCC registration routes
Supply against MoH registration held by your local licensed importer, or via the GCC central registration pathway.
UK unlicensed routes
Where no UK licence exists, the MHRA Specials and named-patient import routes cover clinically justified demand.
Tender desks
Bid-pack documentation assembled to the tender's specification, from CoPP to batch records.
Dossier support
CTD documentation from the sourcing manufacturer, compiled for your regulator's format.
What the dispensing pharmacist checks on famciclovir.
Famciclovir dosing is regimen-, not weight-based, and it changes by indication rather than following one fixed course: herpes zoster is 500 mg every 8 hours for 7 days, recurrent genital herpes is 1000 mg twice daily for a single day, herpes labialis is a single 1500 mg dose, and suppressive therapy is 250 mg twice daily, so pack-mix planning should reflect which indication a tender specifies. Efficacy for herpes zoster depends on early initiation, within 72 hours of rash onset, and for genital herpes recurrences, within 6 hours of first symptom, so buyers supplying urgent-care or sexual-health clinics value fast fulfilment. Dosage must be reduced according to creatinine clearance in renal impairment; cases of acute renal failure have been reported where this adjustment was missed. Famciclovir is contraindicated in patients with known hypersensitivity to penciclovir cream (Denavir). It is a room-temperature, ambient-logistics oral tablet: no cold chain, no light-sensitivity handling and no reconstitution are required, and shelf-stable storage keeps freight simple for landlocked and tender-cycle destinations.
The documentation pack a regulator actually asks for.
As an oral solid dosage form, famciclovir travels on standard ambient-temperature logistics rather than the cold-chain lanes M Care validates for biologics and insulins. What buyers need instead is batch-level certificate of analysis, CDSCO export documentation and, where the destination market requires it, CTD or eCTD-format dossier support so the buyer's own regulator can register the product. Famciclovir is not currently listed on the WHO Model List of Essential Medicines; aciclovir is the antiviral WHO lists for herpes simplex and herpes zoster, so buyers should treat famciclovir as a formulary-specific alternative rather than an EML first-line agent when building a tender specification. It is not a controlled substance and carries no boxed warning. On the brand-versus-generic question, Famvir remains the originator product; FDA-approved generic famciclovir tablets from multiple manufacturers have been registered in the US since the mid-2000s and sit alongside MHRA-authorised generic famciclovir in the UK, so buyers genuinely have a brand-or-generic choice. Multiple Indian WHO-GMP partner lines on the M Care roster give tender desks an alternative to a single-source formulary risk.
Permit sequence, registration status and customs handling are documented in importing medicines from India through the licensed route; this page sticks to what is specific to the molecule.
CoA and MoA, per batch
Batch-specific certificate and method of analysis from the sourcing manufacturer's QC release.
CoPP, WHO-GMP, MFG licence
Certificate of pharmaceutical product and site GMP certification issued via CDSCO channels, naming the actual manufacturing site.
CTD Module 3
Chemistry, manufacturing and controls documentation available from the sourcing manufacturer for registration filings.
Pack insert, labels, artwork
Destination-language patient information and labelling to the local regulator's standard, locked before shipment.
Pharmacovigilance
A named PV contact arranged in the destination market where the registration requires one.
Adjacent lines procurement desks order alongside famciclovir.
Molecule · strength · volume · destination. One working day to a quote.
- Send us the specifics. Form and strength, pack preference, destination market and indicative volume for famciclovir.
- We route to the right line. The enquiry goes to the WHO-GMP certified manufacturing partner whose certificates fit your regulator.
- Commercial and regulatory offer. FOB or CIF price with the documentation list, named manufacturing site and current certificate validity.
- Order, produce, release, ship. QC release on the Indian side, batch documents compiled, despatch on the agreed incoterm.
- After delivery. Batch records and certificates archived and retrievable for the life of the product on your shelf.
Famciclovir supply, the specific questions.
Does a generic version of Famvir exist?
Yes. FDA-approved generic famciclovir tablets have been registered in the US since the mid-2000s, and MHRA-authorised generic famciclovir is separately available in the UK, alongside the originator brand Famvir. Registration status for generic famciclovir varies by destination country, so M Care checks local approval before quoting brand or generic against a specific tender.
Can M Care supply Famvir to our market?
Yes, on an import basis. We source Famvir through licensed Indian distribution channels and dispatch against your import authorisation and any local registration your pharmacy, hospital or wholesaler holds.
What strengths of famciclovir tablets are available?
125 mg, 250 mg and 500 mg film-coated tablets, matching the Famvir strengths. Tell us your indication mix, herpes zoster, recurrent genital herpes, herpes labialis or suppressive therapy, and we quote the strength split accordingly.
Why would a formulary specify famciclovir over aciclovir or valaciclovir?
Famciclovir offers simpler dosing schedules for some indications, a single 1500 mg dose for herpes labialis and 1000 mg twice daily for one day for recurrent genital herpes, compared with aciclovir's multiple-times-daily regimens. It is not on the WHO Essential Medicines List, which names aciclovir as the reference antiviral for herpes simplex and zoster, so tender desks typically specify famciclovir where a formulary already stocks it or a prescriber prefers its dosing convenience.
Does famciclovir need cold-chain handling?
No. Famciclovir tablets are stored at controlled room temperature, 20 to 25 degrees Celsius with excursions to 15 to 30 degrees Celsius permitted, and need no light-sensitivity precautions or reconstitution. It travels on standard ambient logistics, which keeps freight and warehousing straightforward for tender-cycle and landlocked destinations.
Is famciclovir dosed differently in patients with kidney impairment?
Yes. Dosage must be reduced according to the patient's creatinine clearance for every indication, and cases of acute renal failure have been reported in patients with underlying renal disease who received doses not adjusted for their level of renal function. Prescribers should confirm the renal-adjusted regimen before dispensing, particularly for older patients.
Who stands behind this page, and where its statements come from.
Reviewed by Dr. Rajat Bhatt, PharmD, Managing Director, M Care Exports. Last reviewed 2026-09-19.
This page is sourcing information for licensed importers, hospital procurement and tender desks. It is not medical, pharmaceutical or prescribing advice, and it is not a substitute for the approved product information of the line on your order. See our full disclaimer.
Send the specifics. You'll have a price inside one working day.
Form and strength, destination market and indicative volume. The Mumbai desk replies within one working day, including when the honest answer is that the route is not viable yet.